Breast carcinoma survival in Europe and the United States
Open Access
- 29 December 2003
- Vol. 100 (4), 715-722
- https://doi.org/10.1002/cncr.20038
Abstract
BACKGROUND Breast carcinoma survival rates were found to be higher in the U.S. than in Europe. METHODS Multiple regression analysis of breast carcinoma survival rates among women diagnosed between 1990 and 1992 was performed using clinical data from population‐based case series from the Surveillance, Epidemiogy, and End Results (SEER) program (13,172 women) and the European Concerted Action on survival and Care of Cancer Patients (EUROCARE) project (4478 women). RESULTS Early‐stage tumors (T1N0M0) were more frequent in the SEER data (41% of cases) than in the EUROCARE data (29%). In the SEER data, early tumors were more frequent in women age ≥ 65 years (43%) than in younger women (38%), whereas the reverse was true in the European data (25% vs. 31%). In both case series, > 90% of women underwent surgery and 81–82% underwent lymphadenectomy, but the number of axillary lymph nodes evaluated was higher in the SEER data than in the EUROCARE data. The 5‐year survival rate was higher in the U.S. case series (89%) than in the European series (79%). This differential was observed for each stage category evaluated: early (T1N0M0), large lymph node‐negative (T2–3N0M0), lymph node‐positive (T1–3N+M0), locally advanced (T4M0), and metastatic (M1) tumors. The overall relative excess risk (RER) of death was significantly higher (RER, 1.37; 95% confidence interval [95% CI], 1.25–1.50) among European women compared with U.S. women (referent group). Adjustment for stage, age, surgery, and the number of lymph nodes evaluated explained most of the excess risk (RER, 1.07; 95% CI, 0.98–1.17). CONCLUSIONS Transatlantic differences in the 5‐year survival rates for women diagnosed with breast carcinoma between 1990 and 1992 were attributable mainly to differences in stage of disease. Resources should be invested to achieve earlier diagnosis of breast carcinoma in Europe, especially for elderly women. Cancer 2004;100:715–22. © 2003 American Cancer Society.Keywords
Funding Information
- BIOMED Programme of the European Community
- Europe Against Cancer Programme (European Breast Cancer Screening Network) (2000/CAN/201)
This publication has 22 references indexed in Scilit:
- Regression models for relative survivalStatistics in Medicine, 2003
- Stage at diagnosis is a key explanation of differences in breast cancer survival across EuropeInternational Journal of Cancer, 2003
- Race, Socioeconomic Status, and Breast Cancer Treatment and SurvivalJNCI Journal of the National Cancer Institute, 2002
- Differences in stage and therapy for breast cancer across EuropeInternational Journal of Cancer, 2001
- Variations in survival from breast cancer in Europe by age and country, 1978–1989European Journal of Cancer, 1998
- Recent trends in breast cancer mortality among white and black US women.American Journal of Public Health, 1997
- Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort studyBMJ, 1997
- Relative survival and the estimation of net survival: Elements for further discussionStatistics in Medicine, 1990
- A computer program package for relative survival analysisComputer Programs in Biomedicine, 1985
- The Will Rogers PhenomenonThe New England Journal of Medicine, 1985